AYALA PHARMACEUTICALS INC's ticker is AYLA and the CUSIP is 05465V108. A total of 12 filers reported holding AYALA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $15,000 | -54.5% | 14,913 | -51.2% | 0.00% | – |
| Q2 2022 | $33,000 | -88.6% | 30,570 | -57.8% | 0.00% | – |
| Q1 2022 | $289,000 | +114.1% | 72,517 | +484.5% | 0.00% | – |
| Q1 2021 | $135,000 | -43.8% | 12,407 | -41.2% | 0.00% | – |
| Q4 2020 | $240,000 | -44.1% | 21,102 | -42.1% | 0.00% | -100.0% |
| Q3 2020 | $429,000 | -30.8% | 36,427 | -41.0% | 0.00% | 0.0% |
| Q2 2020 | $620,000 | – | 61,786 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 542,977 | $5,533,000 | 1.38% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 23,364 | $238,000 | 0.11% |
| Redmile Group, LLC | 667,816 | $6,805,000 | 0.10% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 31,962 | $326,000 | 0.01% |
| Marshall Wace North America L.P. | 49,266 | $502,000 | 0.00% |
| WELLINGTON MANAGEMENT GROUP LLP | 704,363 | $7,178,000 | 0.00% |
| Chevy Chase Trust Holdings, LLC | 15,000 | $153,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 470 | $4,000 | 0.00% |
| UBS Group AG | 5,509 | $56,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |